Alignment Healthcare

Alignment Healthcare, Inc. operates as holding company. The company offers consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and also partners with select health plans to help deliver better benefits at lower costs. The company was founded in 2013 and is headquartered Orange, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Alignment Healthcare reports strong Q4 results, eyes growth opportunities

Alignment Healthcare's Q4 2022 performance showcased revenue growth and membership expansion, underpinned by successful programs and strategic pillars. While challenges in profitability persist, opportunities in program optimization and strategic focus areas offer avenues for future growth.

Alignment Healthcare reports robust Q1 growth and strategic positioning

Alignment Healthcare's strong Q1 performance and strategic positioning under new CMS changes reflect growth potential. Challenges lie in achieving profitability targets and managing potential M&A opportunities cautiously. The company's focus on member retention and operational efficiency bodes well for future success.

Alignment Healthcare reports robust Q2 results, eyes shared risk growth

Alignment Healthcare's Q2 performance was strong, with revenue growth and membership increase. The company is addressing challenges in profitability and market variability while focusing on enhancing broker relationships and shared risk business. Opportunities exist in targeted market expansions and product strategy improvements.

Alignment Healthcare surpasses Q3 expectations, eyes growth amid challenges

Alignment Healthcare exceeded Q3 expectations with strong revenue and membership growth, showcasing momentum and strategic positioning for future success.
Despite challenges related to Union dynamics and potential Medicare rate fluctuations, the company remains confident in achieving its guidance and aims for continued growth.
By leveraging strengths like partnerships, innovative initiatives, and a focus on member experience, Alignment Healthcare is well-positioned for growth and financial stability.

Alignment Healthcare reports robust Q4 growth amidst reimbursement challenges

Alignment Healthcare demonstrated strong financial performance in Q4 2023, despite facing reimbursement challenges and EBITDA losses.
The company's focus on brand recognition, care model portability, and unique risk models in California positions them well for growth and profitability.
Investments in technology, membership growth projections, and positive regulatory changes offer opportunities for Alignment Healthcare to enhance operational efficiency and market position.

Alignment Healthcare reports robust Q1 growth, eyes 20% membership increase

Alignment Healthcare's Q1 2024 earnings call highlighted strong growth in membership and revenue, exceeding expectations in adjusted EBITDA. The company is confident in its ability to grow membership by 20% in 2025, leveraging its unique capabilities and operational model. Challenges in inpatient costs and care navigation require continuous improvement efforts.

Alignment Healthcare reports strong Q2 growth and targets market expansion

Alignment Healthcare demonstrated robust growth in membership, revenue, and profitability in Q2 2024, positioning itself as a key player in the MA plans sector.
The company's strategic focus on profitable growth, market share expansion, and quality service delivery underscores its commitment to sustainable success.
While facing challenges in achieving profitability targets, Alignment Healthcare remains optimistic about its growth prospects and market positioning.

Alignment Healthcare excels in Q3, poised for sustained growth

Alignment Healthcare's Q3 2024 performance reflects strong growth, profitability, and strategic positioning in the Medicare Advantage sector.
With a focus on maintaining high plan ratings, investing in key markets, and enhancing healthcare capabilities, Alignment is poised for continued success.
While challenges in meeting financial expectations and industry dynamics persist, Alignment's strengths and opportunities position it for sustainable growth and competitiveness.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Alignment Healthcare, Inc. operates as a holding company. The company offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered Orange, CA.

New data details Medicare Advantage company's ongoing commitment to environmental, social and governance priorities New data details Medicare Advantage company's ongoing commitment to environmental, social and governance priorities

Better Health Outcomes for Seniors, Improved Access to Care and Reduced Environmental Footprint Are Top Achievements Noted in Alignment Healthcare's 3rd Annual ESG Report

Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Alignment Healthcare (ALHC) Surges 11.5%: Is This an Indication of Further Gains?

ORANGE, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2024 financial results on Thursday, Aug. 1, 2024, after market close. Following the release, the company will host a conference call to review its financial results at 5:30 p.m. EDT.

Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024

ORANGE, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at William Blair's 44th Annual Growth Stock Conference in Chicago on Wednesday, June 5, at 12:40 p.m. CDT.

Alignment Healthcare to Present at William Blair's 44th Annual Growth Stock Conference

Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants John Kao - Founder and Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants Nathan Rich - Goldman Sachs Ryan Daniels - William Blair John Ransom - Raymond James Adam Ron - Bank of America Whit Mayo - Leerink Partners Jess Tassan - Piper Sandler John Ransom - Raymond James Operator Good afternoon, and welcome to Alignment Healthcare's First Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions] Please note that this event is being recorded.

Alignment Healthcare, Inc. (ALHC) Q1 2024 Earnings Call Transcript

While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Alignment Healthcare (ALHC) Q1 Earnings: A Look at Key Metrics

Alignment Healthcare (ALHC) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.20 per share a year ago.

Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

ORANGE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its first quarter ended March 31, 2024.

Alignment Healthcare Reports First Quarter 2024 Results

Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline

ORANGE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2024 financial results on Thursday, May 2, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT.

Alignment Healthcare to Announce First Quarter 2024 Financial Results and Host Conference Call Thursday, May 2, 2024

NEW YORK , March 19, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. ("Alignment" or the "Company") (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

ORANGE, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that Thomas Freeman, chief financial officer, will participate in a virtual fireside conversation hosted by Raymond James on Friday, March 8, at 10 a.m. EST.

Alignment Healthcare to Participate in a Virtual Fireside hosted by Raymond James

NEW YORK--(BUSINESS WIRE)---- $ALHC #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. (“Alignment” or “the Company”) (NASDAQ: ALHC). Investors who purchased Alignment securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ALHC. Investigation Details: On or around March 29, 2021, Alignment conducted its initial public offering (“IPO”),.

Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, NY / ACCESSWIRE / March 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alignment Healthcare, Inc. ("Alignment Healthcare") (NASDAQ:ALHC) concerning possible violations of federal securities laws. Alignment conducted its initial public offering ("IPO"), selling 27.2 million shares of common stock priced at $18.00 per share.

Levi & Korsinsky Reminds Alignment Healthcare Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALHC

Levi & Korsinsky, LLP Investigates Possible Securities Fraud Violations by Alignment Healthcare, Inc. (ALHC)

NEW YORK, NY / ACCESSWIRE / March 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alignment Healthcare, Inc. ("Alignment Healthcare") (NASDAQ:ALHC) concerning possible violations of federal securities laws. Alignment conducted its initial public offering ("IPO"), selling 27.2 million shares of common stock priced at $18.00 per share.

Levi & Korsinsky Reminds Shareholders of an Investigation into Alignment Healthcare, Inc. (ALHC) Regarding Potential Securities Fraud Allegations

ATTENTION ALHC SHAREHOLDERS: Investors who lost money on Alignment Healthcare, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

NEW YORK, NY / ACCESSWIRE / March 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alignment Healthcare, Inc. ("Alignment Healthcare") (NASDAQ:ALHC) concerning possible violations of federal securities laws. Alignment conducted its initial public offering ("IPO"), selling 27.2 million shares of common stock priced at $18.00 per share.

Alignment Healthcare, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ALHC

Lost Money on Alignment Healthcare, Inc.(ALHC)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / March 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alignment Healthcare, Inc. ("Alignment Healthcare") (NASDAQ:ALHC) concerning possible violations of federal securities laws. Alignment conducted its initial public offering ("IPO"), selling 27.2 million shares of common stock priced at $18.00 per share.

ALHC ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (ALHC) Q4 2023 Earnings Call Transcript

The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Alignment Healthcare (ALHC) Reports Q4 Earnings: What Key Metrics Have to Say

ORANGE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its fourth quarter and full year ended Dec. 31, 2023.

Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full-Year 2024 Financial Guidance

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alignment Healthcare (ALHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.

Stay Ahead of the Game With Alignment Healthcare (ALHC) Q4 Earnings: Wall Street's Insights on Key Metrics

Alignment Healthcare (ALHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for Alignment Healthcare Stock (ALHC)